Canadian scientists have found what appears to be the first effective treatment for SARS, a "profoundly" important advance should the rogue virus resurface.
|
With tuberculosis killing one person every 15 seconds, half a million of the world's poorest TB patients are set to benefit from free life-saving drugs under an agreement signed today by the United Nations World Health Organization (WHO) and the pharmaceutical company, Novartis.
|
A study published in the December issue of Archives of Neurology and currently available online shows that levetiracetam reduced phasic spasticity, which is marked by spasms and painful muscle cramps, in 100 percent of patients in a small clinical study.
|
University of North Carolina researchers have found a compound that blocks activity of Neuropeptide Y (NPY) — a neurotransmitter that is integral to functions such as anxiety, pain, memory and feeding behaviours — can also decrease both the onset as well as the repetition of alcohol consumption.
|
People with diabetes can help keep their bodies healthy by simply adding a dash of spice to their diet, new research reports.
|
People with diabetes can help keep their bodies healthy by simply adding a dash of spice to their diet, new research reports.
|
A study led by Imperial College London has shown for the first time it is possible to help prevent organ rejection using a novel strategy that redirects the body's immune response instead of suppressing it.
|
Researchers at Duke University Medical Center have developed a new breast scanner that is designed to detect subtle changes in breast cells before a lump can be felt by hand or seen with X-ray mammography.
|
In what may prove to be an important step toward the development of a protective SARS vaccine, researchers have genetically altered a common cold virus that appears to trigger a SARS-fighting immune response in monkeys.
|
An artificial blood product developed by researchers at the Albert Einstein College of Medicine is showing great promise in ongoing clinical trials in Stockholm, Sweden - the first time that a blood substitute has ever been used successfully in humans. The Einstein researchers - whose work is supported by $2.2 million in grants from the National Institutes of Health and the U.S. Army -- are also fine-tuning a powder version of the substitute that can be reconstituted for use as needed with the simple addition of water.
|
Zapping bugs which flourish in office ventilation systems with ultraviolet radiation could cut the sickness suffered by millions of office workers, suggests a new study.
|
The blizzard of new findings presented at the American Heart Association's recent annual meeting show just how far science is progressing: There are now defibrillators that are easier to use than a VCR and techniques that may enable a damaged heart to repair itself.
|
State and federal health officials said Saturday that Pennsylvania's hepatitis A outbreak is winding down, even as the number of those infected climbed over 600. The investigation shifted to how green onions linked to the outbreak became contaminated.
|
Back pain is so widespread that up to 80 per cent of us are likely to have it at some time in our lives - after headache and the common cold, it's the most common cause of time off work. But the good news is that most back pain is caused by only minor problems and usually improves within two weeks.
|
|
|
